Mochi Health, MD-Led Platform

Mochi Health is an online obesity medicine clinic founded in 2022 that combines GLP-1 prescribing with optional metabolic lab testing to provide a more clinically grounded approach than many direct-to-consumer weight loss platforms. The company operates on a membership model, charging a monthly fee that covers unlimited provider visits and access to the Mochi app alongside the cost of medication. The clinical differentiator is metabolic testing. Through a partnership with Quest Diagnostics, Mochi patients can order at-home lab panels covering A1C and fasting glucose, lipid panels with high-sensitivity CRP, thyroid function (TSH/free T4), and kidney function markers. These results inform medication selection and dosing rather than relying solely on BMI and self-reported health history — an approach that more closely mirrors what a patient might receive from an in-person obesity medicine specialist. Mochi offers two medication tracks. Compounded semaglutide is available at a flat $99/month regardless of dose, and compounded GLP-1/GIP (tirzepatide equivalent) is priced at $199/month. For patients with commercial insurance, Mochi provides prior authorization support for brand-name medications including Wegovy, Zepbound, and Ozempic. The membership fee ($79/month, first month at $39) applies regardless of which track a patient chooses and is not covered by insurance. The platform does not offer structured behavioral coaching or dietitian-led sessions, which distinguishes it from higher-cost programs like Calibrate or Form Health. However, the combination of optional lab infrastructure and both insurance and cash-pay pathways makes Mochi more clinically capable than purely async platforms that prescribe without any metabolic context. Mochi Health operates across a broad range of states and has grown rapidly since launch, positioning itself between budget compounding services and full-featured obesity medicine programs. For patients who want more than a prescription but less than a year-long structured program, Mochi represents a reasonable middle ground — provided they are comfortable with the membership fee stacking on top of medication costs. The company operates on a membership model, charging a monthly fee that covers unlimited provider visits and access to the Mochi app alongside the cost of medication. The clinical differentiator is metabolic testing. Through a partnership with Quest Diagnostics, Mochi patients can order at-home lab panels covering A1C and fasting glucose, lipid panels with high-sensitivity CRP, thyroid function (TSH/free T4), and kidney function markers. These results inform medication selection and dosing rather than relying solely on BMI and self-reported health history — an approach that more closely mirrors what a patient might receive from an in-person obesity medicine specialist. Mochi offers two medication tracks. Compounded semaglutide is available at a flat $99/month regardless of dose, and compounded GLP-1/GIP (tirzepatide equivalent) is priced at $199/month. For patients with commercial insurance, Mochi provides prior authorization support for brand-name medications including Wegovy, Zepbound, and Ozempic. The membership fee ($79/month, first month at $39) applies regardless of which track a patient chooses and is not covered by insurance. The platform does not offer structured behavioral coaching or dietitian-led sessions, which distinguishes it from higher-cost programs like Calibrate or Form Health. However, the combination of optional lab infrastructure and both insurance and cash-pay pathways makes Mochi more clinically capable than purely async platforms that prescribe without any metabolic context. Mochi Health operates across a broad range of states and has grown rapidly since launch, positioning itself between budget compounding services and full-featured obesity medicine programs. For patients who want more than a prescription but less than a year-long structured program, Mochi represents a reasonable middle ground — provided they are comfortable with the membership fee stacking on top of medication costs.